Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

摘要: Objectives To measure the effect of adverse events within 35 days transrectal ultrasound guided biopsy from perspective asymptomatic men having prostate specific antigen (PSA) testing; to assess early attitude re-biopsy; estimate healthcare resource use associated with due biopsy; and develop a classification scheme for reporting after biopsy. 8.2, P<0.001) symptoms related infection (7.9, bleeding (4.2, P<0.001); differences were evident between centres (P<0.001). 119/1147 (10.4%, 8.7% 12.3%) reported consultation professional (usually their general practitioner), most commonly infective symptoms. Complete data all index at time points available in 851 participants. Symptoms could be used grade these as follows: 0 (no symptoms/contact) 18 (2.1%, 1.3% 3.3%); 1 (minor problem/no contact) 550 (64.6%, 61.4% 67.8%); 2